Država: Irska
Jezik: engleski
Izvor: HPRA (Health Products Regulatory Authority)
Risperidone
Chanelle Medical Unlimited Company
N05AX; N05AX08
Risperidone
1 milligram(s)/millilitre
Oral solution
Product subject to prescription which may not be renewed (A)
Other antipsychotics; risperidone
Not marketed
2006-12-15
_ _ _ _ _ _ _ _ _Page 1 of 13 _ PACKAGE LEAFLET: INFORMATION FOR THE USER RISPERIDONE 1 MG/ML ORAL SOLUTION Risperidone READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET : 1. What Risperidone Oral Solution is and what it is used for 2. What you need to know before you take Risperidone Oral Solution 3. How to take Risperidone Oral Solution 4. Possible side effects 5. How to store Risperidone Oral Solution 6. Contents of the pack and other information 1. WHAT RISPERIDONE ORAL SOLUTION IS AND WHAT IT IS USED FOR Risperidone Oral Solution belongs to a group of medicines called ‘anti-psychotics’. Risperidone Oral Solution is used to treat the following: • Schizophrenia, where you may see, hear or feel things that are not there, believe things that are not true or feel unusually suspicious, or confused • Mania, where you may feel very excited, elated, agitated, enthusiastic or hyperactive Mania occurs in an illness called “bipolar disorder” • Short-term treatment (up to 6 weeks) of long-term aggression in people with Alzheimer’s dementia, who harm themselves or others. Alternative (non-drug) treatments should have been used previously • Short-term treatment (up to 6 weeks) of long-term aggression in intellectually disabled children (at least 5 years of age) and adolescents with conduct disorder. Risperidone Oral Solution can help alleviate the symptoms of your disease and stop your symptoms from coming back. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE RISPERIDONE ORAL SOLUTION DO NOT TAKE Pročitajte cijeli dokument
HealthProductsRegulatoryAuthority 12May2022 CRN00CT24 Page1of19 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Risperidone1mg/mlOralSolution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Eachmlof solutioncontains 1mgofrisperidone. Excipientswithknowneffect: 1mloforalsolutioncontains1.5mgofBenzoicacid(E210) For thefulllistofexcipients,seesection6.1. 3 PHARMACEUTICAL FORM TheOralsolutionisclearandcolourless. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Risperidoneisindicatedforthetreatmentofschizophrenia. Risperidoneisindicatedforthetreatmentofmoderatetoseveremanicepisodesassociatedwithbipolardisorders. Risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer's dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Risperidoneisindicatedfortheshort-termsymptomatictreatment(upto6weeks)ofpersistentaggressioninconductdisorder inchildrenfromtheageof5yearsandadolescentswithsubaverageintellectualfunctioningormentalretardationdiagnosed according to DSM-IV criteria, in whom the severity of aggressive or other disruptive behaviors require pharmacologic treatment. Pharmacological treatment should be an integral part of a more comprehensive treatment programme, including psychosocialandeducationalintervention.Itisrecommendedthatrisperidonebeprescribedbyaspecialistinchildneurology and child and adol Pročitajte cijeli dokument